These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 23805596

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sublingual immunotherapy in children: more optimism today.
    Larenas-Linnemann D.
    Pediatr Allergy Immunol; 2009 Jun; 20(4):399-400; author reply 401. PubMed ID: 18823357
    [No Abstract] [Full Text] [Related]

  • 3. [Allergen-specific immunotherapy (hyposensitization). Part 2. Oral, sublingual and nasal application].
    Fuchs T, Klimek L.
    HNO; 2000 Feb; 48(2):158-64. PubMed ID: 10663067
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sublingual immunotherapy for allergic rhinitis: an update.
    Passalacqua G, Compalati E, Canonica GW.
    Curr Opin Otolaryngol Head Neck Surg; 2011 Feb; 19(1):43-7. PubMed ID: 21102336
    [Abstract] [Full Text] [Related]

  • 7. Sublingual immunotherapy.
    Lin SY, Leatherman B.
    Otolaryngol Clin North Am; 2011 Jun; 44(3):753-64, x-xi. PubMed ID: 21621059
    [Abstract] [Full Text] [Related]

  • 8. Do indications to sublingual immunotherapy need to be revised?
    Incorvaia C, Mauro M.
    J Allergy Clin Immunol; 2010 Jan; 125(1):277; author reply 277-8. PubMed ID: 20109757
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sublingual immunotherapy and regulatory T cells.
    Ciprandi G, Fenoglio D, Cirillo I, Milanese M, Minuti P.
    Allergy; 2006 Apr; 61(4):511-3. PubMed ID: 16512819
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sublingual Immunotherapy for Allergic Rhinitis: Is 2-Year Treatment Sufficient for Long-term Benefit?
    Cox LS.
    JAMA; 2017 Feb 14; 317(6):591-593. PubMed ID: 28196239
    [No Abstract] [Full Text] [Related]

  • 15. [Allergen specific immunotherapy: new approaches].
    Tay F, Kündig TM, Senti G.
    Praxis (Bern 1994); 2010 Oct 20; 99(21):1279-84. PubMed ID: 20960398
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
    Pfaar O, Hörmann K, Klimek L.
    MMW Fortschr Med; 2006 Feb 02; 148(5):28-32. PubMed ID: 16518935
    [Abstract] [Full Text] [Related]

  • 18. Sublingual immunotherapy for allergic rhinitis.
    Wilson DR, Torres LI, Durham SR.
    Cochrane Database Syst Rev; 2003 Feb 02; (2):CD002893. PubMed ID: 12804442
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis.
    Lee JE, Choi YS, Kim MS, Han DH, Rhee CS, Lee CH, Kim DY.
    Ann Allergy Asthma Immunol; 2011 Jul 02; 107(1):79-84. PubMed ID: 21704889
    [Abstract] [Full Text] [Related]

  • 20. [Sublingual immunotherapy (SLIT) in the allergologist's practice].
    Mösges R, Köberlein J, Keppler J.
    MMW Fortschr Med; 2008 Jun 26; 150 Suppl 2():79-84. PubMed ID: 18712127
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.